LuxaFlow
Clinical indication(s) / Claim(s)
Verbatim per manufacturer's Instructions-for-use (IFU) sheet

IFU Link
Claim 1: Individualization and repair of temporary bis-acrylates
Claim 2: Small fillings for cavity classes III
Claim 3: Small fillings for cavity classes IV
Claim 4: Small fillings for cavity classes V
Claim 5: Minimally invasive fillings
Claim 6: Underfillings

 
 
 
 

Clinical evidence supporting the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
Clinical evidence not supporting the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
Clinical evidence not related to the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
(c) RCHSR
CQ-Score of the publication
Criterion I = 0 Criterion II  = 0 Criterion III  = 0 / Total score = 0
CQ-Score of the publication
Criterion I = 1 Criterion II  = 0 Criterion III  = 0 / Total score = 0
Claim 4:
Fu Yong. Clinical observation of LuxaFIow flowable resin for filling wedge-shaped defects. Chin J Mod Drug Appl 2014; 8: 109.

Claim 5:
Oz FD, Ergin E, Cakir FY, Gurgan S. Clinical Evaluation of a Self-Adhering Flowable Resin Composite in Minimally Invasive Class I Cavities: 5-year Results of a Double Blind Randomized, Controlled Clinical Trial. Acta Stomatol Croat. 2020 Mar;54(1):10-21.

Claims 1 - 3, 6: